AU2001249267A1 - Methods and compositions for elucidating protein expression profiles in cells - Google Patents

Methods and compositions for elucidating protein expression profiles in cells

Info

Publication number
AU2001249267A1
AU2001249267A1 AU2001249267A AU4926701A AU2001249267A1 AU 2001249267 A1 AU2001249267 A1 AU 2001249267A1 AU 2001249267 A AU2001249267 A AU 2001249267A AU 4926701 A AU4926701 A AU 4926701A AU 2001249267 A1 AU2001249267 A1 AU 2001249267A1
Authority
AU
Australia
Prior art keywords
compositions
methods
protein expression
cells
expression profiles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249267A
Inventor
James N. Higginbotham
Charles J. Link Jr.
Sachet A. Link
Bradley J. Powers
Jay W. Ramsey
Tatiana Seregina
Nicholas N. Vahanian
Won Bin Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewLink Genetics Corp
Original Assignee
NewLink Genetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NewLink Genetics Corp filed Critical NewLink Genetics Corp
Publication of AU2001249267A1 publication Critical patent/AU2001249267A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA

Abstract

The present invention relates generally to methods and compositions for the identification of differential protein expression patterns and concomitantly the active genetic regions that are directly or indirectly involved in different tissue types, disease states, or other cellular differences desirable for diagnosis or for targets for drug therapy.
AU2001249267A 2000-03-20 2001-03-19 Methods and compositions for elucidating protein expression profiles in cells Abandoned AU2001249267A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19067800P 2000-03-20 2000-03-20
US60/190,678 2000-03-20
PCT/US2001/008770 WO2001070948A2 (en) 2000-03-20 2001-03-19 Methods and compositions for elucidating protein expression profiles in cells

Publications (1)

Publication Number Publication Date
AU2001249267A1 true AU2001249267A1 (en) 2001-10-03

Family

ID=22702326

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249267A Abandoned AU2001249267A1 (en) 2000-03-20 2001-03-19 Methods and compositions for elucidating protein expression profiles in cells

Country Status (8)

Country Link
EP (1) EP1268767B1 (en)
JP (1) JP2003527855A (en)
AT (1) ATE312173T1 (en)
AU (1) AU2001249267A1 (en)
CA (1) CA2403567A1 (en)
DE (1) DE60115622T2 (en)
MX (1) MXPA02009257A (en)
WO (1) WO2001070948A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002323398A1 (en) * 2001-08-24 2003-03-10 Health Research, Inc. A high throughput method for identification of sequence tags
US20060094059A1 (en) * 2004-09-22 2006-05-04 Odyssey Thera, Inc. Methods for identifying new drug leads and new therapeutic uses for known drugs
CN106951732B (en) 2010-05-25 2020-03-10 加利福尼亚大学董事会 Genome sequence analysis system based on computer
US9646134B2 (en) * 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
CN113501861A (en) * 2021-08-01 2021-10-15 青海瑞肽生物科技有限公司 Method for screening characteristic fragments of yak collagen by high-resolution mass spectrometry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364783A (en) * 1990-05-14 1994-11-15 Massachusetts Institute Of Technology Retrovirus promoter-trap vectors
US5434065A (en) * 1993-05-06 1995-07-18 President And Fellows Of Harvard College In vivo selection of microbial virulence genes
US5922601A (en) * 1995-01-19 1999-07-13 Biotransplant, Inc. High efficiency gene trap selection of regulated genetic loci
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US6207371B1 (en) * 1996-10-04 2001-03-27 Lexicon Genetics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US5994077A (en) * 1997-01-31 1999-11-30 The Board Of Trustees Of The Leland Stanford Junior University Flourescence-based isolation of differentially induced genes
US6333152B1 (en) * 1997-05-21 2001-12-25 The Johnshopkins University Gene expression profiles in normal and cancer cells
EP1066392B1 (en) * 1998-03-27 2008-07-09 Lexicon Pharmaceuticals, Inc. Vectors for gene mutagenesis and gene discovery
AU3917600A (en) * 1999-03-25 2000-10-09 Massachusetts Institute Of Technology Retroviral vectors and methods for production and use thereof

Also Published As

Publication number Publication date
DE60115622D1 (en) 2006-01-12
EP1268767A2 (en) 2003-01-02
ATE312173T1 (en) 2005-12-15
DE60115622T2 (en) 2006-06-22
EP1268767B1 (en) 2005-12-07
WO2001070948A2 (en) 2001-09-27
WO2001070948A9 (en) 2002-12-19
CA2403567A1 (en) 2001-09-27
JP2003527855A (en) 2003-09-24
MXPA02009257A (en) 2004-04-05
WO2001070948A3 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2001078652A3 (en) Methods for drug discovery, disease treatment, and diagnosis using metabolomics
BRPI0413427A (en) active pyridylpyrrole derivatives as kinase inhibitors
EA200600076A1 (en) COMPOSITIONS AND METHODS OF INCREASING THE ACTIVITY OF TELOMERASE
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
MXPA06000302A (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
MY127369A (en) Quinazoline derivatives
MY143795A (en) Tetrahydropyridoindole derivatives
MXPA02012272A (en) Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv.
WO2004013310A3 (en) Methods of down regulating target gene expression in vivo by introduction of interfering rna
MY139072A (en) Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
BRPI0413438A (en) active pyrimidylpyrrole derivatives as kinase inhibitors
WO2001079164A3 (en) N-substituted dithiocarbamates for the treatment of biological disorders
WO2003017939A3 (en) Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU2001249267A1 (en) Methods and compositions for elucidating protein expression profiles in cells
WO2001041747A3 (en) Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating cancer
CY1111004T1 (en) USEFUL COMPOSITIONS FOR REGULATING PARKIN GENE ACTION
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
HK1050203A1 (en) Novel fusidic acid derivatives.
WO2002012336A3 (en) TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
WO2002047717A3 (en) Targeted enzyme prodrug therapy
WO2004094451A3 (en) 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES
CY1118235T1 (en) TREATMENT OF GLYCOGEN TYPE II STORAGE DISEASES